The estimated Net Worth of Gerard M Jr Hayden is at least $764 mil dollars as of 21 May 2020. Gerard Hayden owns over 10,000 units of IMAC Inc stock worth over $10,100 and over the last 18 years Gerard sold IMAC stock worth over $753,410.
Gerard has made over 15 trades of the IMAC Inc stock since 2013, according to the Form 4 filled with the SEC. Most recently Gerard exercised 10,000 units of IMAC stock worth $10,100 on 21 May 2020.
The largest trade Gerard's ever made was exercising 30,000 units of IMAC Inc stock on 25 July 2013 worth over $94,500. On average, Gerard trades about 6,330 units every 82 days since 2006. As of 21 May 2020 Gerard still owns at least 10,000 units of IMAC Inc stock.
You can see the complete history of Gerard Hayden stock trades at the bottom of the page.
Gerard's mailing address filed with the SEC is C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD, TN, 37027.
Over the last 6 years, insiders at IMAC Inc have traded over $640,000 worth of IMAC Inc stock and bought 19,852 units worth $9,124 . The most active insiders traders include Cary Sucoff, Matthew C Wallis, eGerard M Jr Hayden. On average, IMAC Inc executives and independent directors trade stock every 48 days with the average trade being worth of $25,399. The most recent stock trade was executed by Cary Sucoff on 20 December 2023, trading 3,333 units of IMAC stock currently worth $3,366.
IMAC was created in March 2015 to expand on the footprint of the original IMAC Regeneration Center, which opened in Kentucky in August 2000. IMAC Regeneration Centers combine life-science advancements with traditional medical care for movement restricting diseases and conditions. IMAC owns or manages more than 15 outpatient clinics that provide regenerative, orthopedic and minimally invasive procedures and therapies. It has partnered with several active and former professional athletes including Ozzie Smith, David Price, Mike Ditka and Tony Delk. IMAC’s outpatient medical clinics emphasize treating sports and orthopedic injuries and movement-restricting diseases without surgery or opioids.
IMAC Inc executives and other stock owners filed with the SEC include: